Tracking cryptic SARS-CoV-2 hospital outbreak through quasispecies analysis.

Publication date: Dec 21, 2024

Since the beginning of the pandemic, contact tracing has been one of the most relevant issues to understand SARS-CoV-2 transmission dynamics and, in this context, the analysis of quasispecies may turn out to be a useful tool for outbreak investigations. Analysis of the intra-host single nucleotide variants (iSNVs) found in the nsp2, ORF3, and ORF7 genes of SARS-CoV-2 was conducted in order to correctly identify virus transmission chain among patients hospitalized in Brescia Civic Hospital. During the period between August and October 2023, 13 nasopharyngeal specimens, collected from patients admitted to Brescia Civic Hospital, were tested for SARS-CoV-2 positivity and molecularly characterized. Firstly, a phylogenetic analysis was performed to evaluate if they were epidemiologically linked and, then, the Beta-binomial method was used to estimate the transmission bottleneck size (Nb) and quantify the number of viral particles transmitted from one individual (donor) to another (recipient). According to the molecular characterization of specimens, we identified two transmission clusters in the cardiology unit: the first cluster concerned patients tested positive for the HV. 1/EG. 5.1. 6 lineage, while the second cluster concerned patients tested positive for the FL. 10. 1 lineage. Moreover, evaluating the bottleneck size, we were able to solve SARS-CoV-2 transmission chain among infected patients. Our method shows that it is possible to conduct a tracing study using a genomic approach based on iSNVs analysis.

Open Access PDF

Concepts Keywords
August Adult
Cardiology Aged
Molecular Aged, 80 and over
Pandemic Contact Tracing
Viral COVID-19
Disease Outbreaks
Female
Hospital outbreak
Hospitals
Humans
Italy
Male
Middle Aged
Nasopharynx
Phylogeny
Quasispecies
Quasispecies
SARS-CoV-2
SARS-CoV-2
Traceability
WGS

Semantics

Type Source Name
disease IDO contact tracing
disease IDO host
pathway REACTOME Reproduction
disease MESH COVID 19 pandemic
disease MESH infection
disease MESH immunocompromised hosts
disease IDO infectivity
disease MESH person to person transmission
disease IDO immunodeficiency
disease MESH hepatitis
disease MESH mutation rate
disease IDO country
disease MESH emergency
drug DRUGBANK Esomeprazole
pathway REACTOME Immune System
drug DRUGBANK Fenamole
disease MESH viral diseases
disease MESH avian influenza
disease MESH infectious diseases
disease MESH Influenza
disease MESH Healthcare Associated Infections
disease MESH imported infections
disease IDO virulence

Original Article

(Visited 3 times, 1 visits today)